Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Cover ArticleArticles, Neurobiology of Disease

Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates

Eva Teuling, Suaad Ahmed, Elize Haasdijk, Jeroen Demmers, Michel O. Steinmetz, Anna Akhmanova, Dick Jaarsma and Casper C. Hoogenraad
Journal of Neuroscience 5 September 2007, 27 (36) 9801-9815; DOI: https://doi.org/10.1523/JNEUROSCI.2661-07.2007
Eva Teuling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suaad Ahmed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elize Haasdijk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeroen Demmers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel O. Steinmetz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Akhmanova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dick Jaarsma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Casper C. Hoogenraad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Distribution and localization of VAPB in vivo. A, Antisera against VAPA and VAPB were made against GST-VAP fusion proteins containing amino acids 1–225 of VAPB (antibody #1006-00) and amino acids 132–225 of VAPA (#1006-04) and VAPB (#1006-02). cc, Coiled-coil region; TM, transmembrane domain. B, C, Cells were fixed and processed for immunofluorescence using antibodies to VAP (green) and PDI (red). D–F, Lysates of COS-1 cells expressing VAP and control proteins (D), cultured cells (E), and mouse CNS (F) were analyzed by immunoblotting using VAP antibodies. G–I, Low- (G1, H1, I1) and high-magnification (G2, H2, H3, I2) of immunoperoxidase stainings using anti-VAPB antibody #1006-00 in murine dorsal hippocampus (G), cerebellum (H), and spinal cord (I). VAPB is expressed at high levels in motor neurons (I2) and large neurons in the cerebellar nuclei (CN; H1, H3) compared with neurons in cerebellar cortex (H1) including cerebellar Purkinje cells (PCs; H2) and hippocampus (G), including hippocampal pyramidal cells (G2). DG, Dentate gyrus; pyr, pyramidal layer; rad, stratum radiatum of CA1 hippocampal subfield; gl, granule-cell layer; ml, molecular layer; wm, white matter. J, K, Double-labeling confocal immunofluorescence of VAPB immunoreactivity (green) and ribosomal protein P0 (red) in mouse spinal motor neurons (J) and dorsal horn neurons (K). VAPB (J1, K1) colocalizes with P0 (J2, K3) in motor neurons, but shows low expression levels in most dorsal horn neurons. A merge is shown on the right. L, Immunoperoxidase staining using anti-VAPB antibody #1006-00 in human lumbar motor neurons (L1), ventral root motor axons (L2), and CA1 hippocampal pyramidal neurons (L3). As in mouse, in human VAPB-immunoreactivity in motor neurons is considerably higher than in other neurons, showing a Nissl body-like distribution (L1). Scale bars: G1, I1, 200 μm; H1, 100 μm; G2, H2, H3, I2, 10 μm; J3, K3, 20 μm; L1, L2, L3, 30 μm.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    The P56S mutation leads to aberrant aggregation of VAPA and VAPB. A–D, HeLa cells expressing HA-tagged VAPB-wt (A), VAPB-P56S (B, D), and VAPA-P56S (C) were fixed and processed for immunofluorescence using antibodies against HA (green) and the ER marker calreticulin (red). HeLa cells in D were incubated for 2 h at 20°C before fixation. Enlargement of boxed regions indicated in the merged pictures is shown at right. E, Lysates (L) of COS-1 cells transfected with HA-VAPB-wt and HA-VAPB-P56S were solubilized with Triton X-100, fractionated in supernatant (S), and pellet (P) under nonreducing (−DTT) or reducing (+DTT) conditions and analyzed by immunoblotting using anti-HA antibodies. Cells were either maintained at 37°C or incubated for 2 h at 20°C before lysis. F, Quantification of the number of VAPB-P56S clusters per cell, incubated at 15 or 20°C for 3 h or treated with 5 μg/μl BFA or 10 μm Nocodazole (Noco) for 30 min, as indicated. Error bars indicate SEM. **p < 0.005%. Scale bar, 10 μm.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Electron microscopy analysis of VAPB-P56S aggregates in HeLa cells. A1–C2, Transmission electron photomicrographs of anti-HA immunogold labeled ultrathin sections of HeLa cells transfected with HA-VAPB-P56S. Immunogold labeling is specifically associated with clusters of electron dense tubular profiles (A). Occasionally, labeled profiles are continuous with unlabeled profiles reminiscent of ER tubules (B) or with mitochondrial outer membranes (C). Arrows indicate unlabeled ER-tubules; asterisks indicate normal appearing cytoplasm in VAPB-P56S aggregates. m, Mitochondria; nu, nucleus. Scale bars: A1, B1, C1, 200 nm; A2, B2, C2, 100 nm.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    VAPB-P56S clusters are immobile porous aggregates. A, Diagram of GFP-tagged VAPB constructs. B, Fluorescent recovery plots compare the rates of recovery of GFP-VAPB-wt (black triangle), GFP-VAPB-P56S (black box), as well as a nonbleached control region (open circles). Fluorescence intensity was normalized to intensity before bleaching. C–E, Representative confocal images of HeLa cells expressing GFP-VAPB-wt and GFP-VAPB-P56S. To visualize the mobility of the GFP-chimeras, small regions of interest of identical size (outlined square in C) were photobleached and monitored for recovery for 300 s (D). Half the area of a VAPB-P56S aggregate was bleached in E. F, Projection of confocal images of a HeLa cell expressing HA-VAPB-P56S and GFP, fixed and stained with anti-HA (red) antibody. Enlargement of the boxed region containing a single confocal stack (0.6 μm) is shown at the bottom. Scale bars, 10 μm.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    VAPB-P56S recruits both wild-type VAPA and VAPB. A, B, HeLa cells transfected with HA-VAPB-P56S (A) or HA-VAPA-P56S (B) and stained with anti-HA (green) and anti-VAPA (red; A) or anti-VAPB (red; B) antibodies. Endog., Endogenous. C, D, HeLa cells double transfected with HA-VAPB-P56S and myc-VAPB-wt (C) or myc-VAPA-wt (D), fixed and stained with anti-HA (green) and anti-Myc antibodies (red) to visualize the expressing VAP protein. E, Lysates (L) of COS-1 cells transfected with HA-VAPB-wt and HA-VAPB-P56S were solubilized with Triton X-100, fractionated in supernatant (S) and pellet (P), and analyzed by immunoblotting using anti-VAPB (#1006-03) antibodies. F, COS-1 cells cotransfected with HA-VAPB-P56S and myc-VAPA-wt or myc-VAPB-wt were immunoprecipitated with control IgG or HA antibodies. The cells were incubated for 2 h at 20°C before lysis to solubilize VAPB-P56S. Each immunoprecipitation reaction is shown in three lanes: I, input to IP reaction; S, supernatant remaining after IP; P, precipitated pellet. The L, I, S, and P samples were immunoblotted for the indicated proteins. G, COS-1 cells cotransfected with HA-VAPB-P56S and GFP-VAPB-wt-N or GFP-VAPB-TMD were immunoprecipitated and immunoblotted as in F. H–K, HeLa cells single or double transfected with GFP-VAPB-TMD (H, J) or GFP-VAPB-wt-N (I, K) and HA-VAPB-P56S (J, K) and stained with anti-calreticulin to reveal the ER (H, I), or anti-HA (J, K) antibodies to visualize the expressing VAP protein. L–N, HeLa cells single or double transfected with GFP-VAPB-P56S-N and HA-VAPB-wt (M) or HA-VAPB-P56S (N) and stained with anti-calreticulin (L) or anti-HA (M, N) antibodies. Scale bar, 10 μm.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    VAPB-P56S disturbs binding to FFAT motif-containing proteins. A–C, HeLa cells double transfected with GFP-FFAT plus HA-VAPB constructs and stained with anti-HA (red) antibodies to visualize the expressing VAP protein. D–F, HeLa cells double transfected with ORP3-GFP plus HA-VAPB constructs and stained with as in A–C. G, COS-1 cells cotransfected with GFP-FFAT and VAPB constructs were immunoprecipitated with GFP antibodies. Each IP reaction is shown in three lanes: I, input to IP reaction; S, supernatant remaining after IP; P, precipitated pellet. The I, S, and P samples were immunoblotted for the indicated proteins. H, COS-1 cells cotransfected with GFP-FFAT and HA-VAPB-wt were immunoprecipitated and immunoblotted as in G. I, Coomassie-stained gel of purified GST-VAPB proteins (top). The GST fusion proteins were loaded with HeLa-cell extracts transfected with GFP-FFAT and GFP-FFAT-SCR, precipitated, and immunoblotted (bottom two panels). Twenty percent of the input (I) is loaded on the gel. J, COS-1 cells cotransfected with ORP3-GFP and HA-VAPB constructs were immunoprecipitated with control IgG and GFP antibodies and immunoblotted as in G. Scale bar, 10 μm.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    VAPB-P56S expression and VAP reduction causes cell death and Golgi fragmentation in primary neurons. A, B, Primary neurons expressing wild-type and mutant HA-tagged VAPA and VAPB were fixed and stained with HA-antibodies (green) and anti-PDI antibodies (red in B). Enlargement of the boxed region containing a single confocal stack (0.8 μm) is shown on the right. C, Primary neurons transfected with wild-type and mutant HA-tagged VAPB and shRNA against VAPA and VAPB (right) at DIV13 for 2 (left, middle) and 6 (right) d and stained with anti-HA (green; left, middle) or anti-β-galactosidase (green, right) and anti-PDI antibodies (red; insets). D, Representative images of primary neurons expressing wild-type (left) and mutant (middle) HA-tagged VAPB and shRNA against VAPA and VAPB (right), fixed and stained with HA-antibodies (green; left, middle) or β-galactosidase (right) and the cis-Golgi marker GM130 (red; insets). E, Quantification of neuronal survival by counting the number of wild-type VAPB-, mutant VAPB-, and β-galactosidase-expressing neurons per coverslip, 2 d (VAPB-WT and mutant) or 6 d (shRNA) after transfection from six and four independent experiments, respectively. F, Quantification of percentage of neurons with dispersed Golgi apparatus of control GFP, wild-type, or mutant VAPB- and shRNA-expressing cells 2 d (VAPB-WT and mutant) or 3 d (shRNA) after transfection. Scale bars: A, 10 μm; C, 100 μm ***p < 0.0005; **p < 0.001; *p < 0.10. Error bars indicate SEM.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Reduced VAPB expression in ALS patients and SOD1-ALS transgenic mice. A1–C3, Immunoperoxidase (A) and confocal immunofluorescence staining (B, C) of VAPB in cervical spinal cord of SOD1-G93A-transgenic ALS mice before symptom onset (A2) and at end-stage disease (A3). VAPB immunoreactivity (green; B2) is not present in ubiquitinated inclusions (red; B3) in motor neurons of symptomatic SOD1-G93A mice (B). Motor neurons displaying Golgi fragmentation visualized by anti-GM130 antibody (red; C2) show reduced VAPB expression (green; C1). D, Western blot analysis of spinal cord homogenates of young nontransgenic (20 weeks), aged nontransgenic (80 weeks), presymptomatic SOD1-G93A (15 weeks and 20 weeks), and symptomatic SOD1-G93A (30 weeks and end-stage) mice. E, F, VAPB-immunoperoxidase staining in control (E) and human ALS (F) lumbar spinal cord. Compared with motor neurons (E3) and pyramidal tract (E2) in control issue, ALS spinal cord sections show a substantial loss of VAPB immunoreactivity in remaining motor neuronal profiles (F3, F4), and reduced staining of the pyramidal tract (F2). pyr, Pyramidal tract. Scal bars: A1–A3; E3, F3, 100 μm; B1, C1, 20 μm; E1, F1, 800 μm; E2, F2, 50 μm.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • supplemental material - Supplemental Material
    • supplemental material - Supplemental Figure 1
    • supplemental material - Supplemental Figure 2
    • supplemental material - Supplemental Figure 3
    • supplemental material - Supplemental Figure 4
    • supplemental material - Supplemental Movie 1
    • supplemental material - Supplemental Movie 2
    • supplemental material - Supplemental Movie 3
Back to top

In this issue

The Journal of Neuroscience: 27 (36)
Journal of Neuroscience
Vol. 27, Issue 36
5 Sep 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates
Eva Teuling, Suaad Ahmed, Elize Haasdijk, Jeroen Demmers, Michel O. Steinmetz, Anna Akhmanova, Dick Jaarsma, Casper C. Hoogenraad
Journal of Neuroscience 5 September 2007, 27 (36) 9801-9815; DOI: 10.1523/JNEUROSCI.2661-07.2007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates
Eva Teuling, Suaad Ahmed, Elize Haasdijk, Jeroen Demmers, Michel O. Steinmetz, Anna Akhmanova, Dick Jaarsma, Casper C. Hoogenraad
Journal of Neuroscience 5 September 2007, 27 (36) 9801-9815; DOI: 10.1523/JNEUROSCI.2661-07.2007
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Neurobiology of Disease

  • The role of retinal dopamine D1 receptors in ocular growth and myopia development in mice
  • ALS-associated KIF5A mutation causes locomotor deficits associated with cytoplasmic inclusions, alterations of neuromuscular junctions and motor neuron loss
  • Perturbed Information Processing Complexity in Experimental Epilepsy
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.